Business Segments Evotec SE

Equities

Market Closed - Xetra Other stock markets 09:05:29 11/07/2025 pm IST			After hours 01:28:00 am
7.046 ^EUR	-2.14%		7.070	+0.34%

09/07	EVOTEC : Deutsche Bank reiterates its Neutral rating	ZD
26/06	EVOTEC : Warburg Research remains its Buy rating	ZD

See more © MarketScreener.com

See more © MarketScreener.com

Breakdown by Business Segment (EUR)

Fiscal Period: December	2020	2021	2022	2023	2024
Life Sciences Tools and Services
Shared R&d	-	-	-	-	61Cr
Gross Profit	-	-	-	-	10Cr
EBITDA	-	-	-	-	1.27Cr
D&A	-	-	-	-	7.72Cr
Operating Income	-	-	-	-	-13Cr
Just - Evotec Biologics	-	-	-	-	19Cr
Gross Profit	-	-	-	-	1.36Cr
EBITDA	-	-	-	-	98.69L
D&A	-	-	-	-	2.44Cr
Operating Income	-	-	-	-	-1.64Cr
EVT Innovate	11Cr	15Cr	20Cr	27Cr	-
Gross Profit	92.24L	-	-	-	-
EBITDA	-2.27Cr	-1.75Cr	-66.02L	10L	-
D&A	30.74L	39.91L	50.87L	54.47L	-
Operating Income	-2.88Cr	-2.21Cr	-1.17Cr	-44.89L	-
EVT Execute	49Cr	61Cr	74Cr	74Cr	-
Gross Profit	13Cr	-	-	-	-
EBITDA	13Cr	12Cr	11Cr	6.54Cr	-
D&A	5.3Cr	6.36Cr	7.66Cr	8.75Cr	-
Operating Income	7.73Cr	6.31Cr	3.25Cr	-4.3Cr	-
Transition	2.18Cr	-	-	-	-
Corporate	-	-	-	-	-
Gross Profit	-	-	-	-	-
Operating Income	-	-	-	-	-
Intersegment Elimination	-12Cr	-14Cr	-19Cr	-22Cr	-12.08L
Gross Profit	-1.04Cr	-	-	-	-9L
Operating Income	-	-	-	-	-

Geographical breakdown of sales (EUR)

Fiscal Period: December	2020	2021	2022	2023	2024
USA	25Cr	-	-	46Cr	45Cr
Total Assets	14Cr	-	-	22Cr	26Cr
Switzerland	-	-	-	6.49Cr	11Cr
Total Assets	1.39Cr	-	-	-	-
Total Assets	28.53L	-	-	26.34L	-
Total Assets	19.86L	-	-	-	-
Total Assets	19.35L	-	-	-	-
United Kingdom	9.4Cr	-	-	8.64Cr	9.25Cr
Total Assets	20Cr	-	-	22Cr	21Cr
Rest of the World	7.77Cr	-	-	9.52Cr	8.23Cr
Germany	4.43Cr	-	-	3.41Cr	3.29Cr
Total Assets	10Cr	-	-	15Cr	15Cr
France	3.71Cr	-	-	3.2Cr	1.99Cr
Total Assets	9.38Cr	-	-	34Cr	33Cr
Total Assets	19Cr	-	-	26Cr	24Cr
Unallocated	-	-	-	-	1.44Cr
Europe	-	-	-	-	-